Jacobs Levy Equity Management, Inc Aurinia Pharmaceuticals Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 748,113 shares of AUPH stock, worth $8.47 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
748,113
Previous 317,656
135.51%
Holding current value
$8.47 Million
Previous $2.55 Million
148.18%
% of portfolio
0.03%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding AUPH
# of Institutions
243Shares Held
62.3MCall Options Held
1.03MPut Options Held
665K-
Tang Capital Management LLC San Diego, CA10MShares$114 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$105 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$44.9 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$31.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$27.1 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.61B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...